Progress in antidepressant effects of pioglitazone / 上海交通大学学报（医学版）
Journal of Shanghai Jiaotong University(Medical Science)
; (12): 1456-1459, 2019.
Article
en Zh
| WPRIM
| ID: wpr-843296
Biblioteca responsable:
WPRO
ABSTRACT
As an agonist of peroxisome proliferator-activated receptor γ (PPARγ), pioglitazone may be involved in the regulation of glycolipid metabolism, oxidative stress and immune inflammatory response, thereby improving depression. Studies find that pioglitazone is effective in treating depression, especially in patients with resistance and comorbid metabolic syndrome, and is expected to be a new treatment for depression. This article reviews the research progress of pioglitazone in clinical application and related mechanisms of depression, in order to provide theoretical basis and support for subsequent research.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Journal of Shanghai Jiaotong University(Medical Science)
Año:
2019
Tipo del documento:
Article